JP2022519696A5 - - Google Patents

Info

Publication number
JP2022519696A5
JP2022519696A5 JP2021546005A JP2021546005A JP2022519696A5 JP 2022519696 A5 JP2022519696 A5 JP 2022519696A5 JP 2021546005 A JP2021546005 A JP 2021546005A JP 2021546005 A JP2021546005 A JP 2021546005A JP 2022519696 A5 JP2022519696 A5 JP 2022519696A5
Authority
JP
Japan
Application number
JP2021546005A
Other languages
Japanese (ja)
Other versions
JP2022519696A (ja
JPWO2020163778A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/017314 external-priority patent/WO2020163778A1/en
Publication of JP2022519696A publication Critical patent/JP2022519696A/ja
Publication of JP2022519696A5 publication Critical patent/JP2022519696A5/ja
Publication of JPWO2020163778A5 publication Critical patent/JPWO2020163778A5/ja
Pending legal-status Critical Current

Links

JP2021546005A 2019-02-07 2020-02-07 Tyk2偽キナーゼリガンド Pending JP2022519696A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962802642P 2019-02-07 2019-02-07
US62/802,642 2019-02-07
PCT/US2020/017314 WO2020163778A1 (en) 2019-02-07 2020-02-07 Tyk2 pseudokinase ligands

Publications (3)

Publication Number Publication Date
JP2022519696A JP2022519696A (ja) 2022-03-24
JP2022519696A5 true JP2022519696A5 (https=) 2023-02-15
JPWO2020163778A5 JPWO2020163778A5 (https=) 2023-02-15

Family

ID=71947508

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021546005A Pending JP2022519696A (ja) 2019-02-07 2020-02-07 Tyk2偽キナーゼリガンド

Country Status (12)

Country Link
US (1) US20220135567A1 (https=)
EP (1) EP3920931A4 (https=)
JP (1) JP2022519696A (https=)
KR (1) KR20210124409A (https=)
CN (1) CN113677347A (https=)
AU (1) AU2020218267A1 (https=)
BR (1) BR112021015616A2 (https=)
CA (1) CA3129438A1 (https=)
IL (1) IL285429A (https=)
MX (1) MX2021009555A (https=)
SG (1) SG11202108619SA (https=)
WO (1) WO2020163778A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019364336B2 (en) 2018-10-22 2023-11-16 Alumis Inc. TYK2 inhibitors and uses thereof
AU2020247990A1 (en) 2019-03-26 2021-11-11 Ventyx Biosciences, Inc. TYK2 pseudokinase ligands
KR102938141B1 (ko) 2019-11-08 2026-03-11 벤틱스 바이오사이언스, 인크. Tyk2 슈도키나제 리간드
AU2021345181A1 (en) * 2020-09-16 2023-05-04 Alumis Inc Tyk2 inhibitors and uses thereof
CN117043164A (zh) * 2021-01-19 2023-11-10 安锐生物医药科技(广州)有限公司 咪唑并哒嗪或吡唑并嘧啶化合物和组合物
JP2024539280A (ja) 2021-10-25 2024-10-28 カイメラ セラピューティクス, インコーポレイテッド Tyk2分解剤およびそれらの使用
WO2025061180A1 (zh) * 2023-09-22 2025-03-27 杭州多域生物技术有限公司 含氮并环类化合物、其药物组合物及其应用
WO2025165746A1 (en) * 2024-01-30 2025-08-07 Ennovathera, Inc. Certain chemical entities, compositions, and methods
WO2025168035A1 (zh) * 2024-02-07 2025-08-14 合肥羿科医药有限公司 杂环类化合物、其药物组合物及其应用
WO2025214467A1 (zh) * 2024-04-12 2025-10-16 江苏恒瑞医药股份有限公司 氨基取代的杂芳环类化合物、其制备方法及其在医药上的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4564485B2 (ja) * 2003-02-28 2010-10-20 帝人ファーマ株式会社 ピラゾロ[1,5−a]ピリミジン誘導体
CN102271515B (zh) * 2008-10-31 2014-07-02 健泰科生物技术公司 吡唑并嘧啶jak抑制剂化合物和方法
US10479793B2 (en) * 2015-11-18 2019-11-19 Bristol-Myers Squibb Company Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
TW201720828A (zh) * 2015-11-23 2017-06-16 赫孚孟拉羅股份公司 治療性化合物及組合物以及其使用方法
JP7160824B2 (ja) * 2017-03-08 2022-10-25 ニンバス ラクシュミ, インコーポレイテッド Tyk2阻害剤、使用およびその製造のための方法
CN110678467B (zh) * 2017-05-22 2023-06-13 豪夫迈·罗氏有限公司 治疗化合物和组合物及其使用方法
KR102717819B1 (ko) * 2017-07-28 2024-10-14 다케다 야쿠힌 고교 가부시키가이샤 Tyk2 억제제 및 이의 용도
JP7179161B2 (ja) * 2018-09-10 2022-11-28 イーライ リリー アンド カンパニー 乾癬および全身性エリテマトーデスの処置に有用なピラゾロ[1,5-a]ピリミジン-3-カルボキサミド誘導体
JP7619951B2 (ja) * 2018-10-15 2025-01-22 武田薬品工業株式会社 Tyk2阻害剤およびその使用
TWI800696B (zh) * 2018-12-10 2023-05-01 美商美國禮來大藥廠 7-(甲基胺基)吡唑并[1,5-a]嘧啶-3-甲醯胺衍生物
KR102938141B1 (ko) * 2019-11-08 2026-03-11 벤틱스 바이오사이언스, 인크. Tyk2 슈도키나제 리간드

Similar Documents

Publication Publication Date Title
JP2022519696A5 (https=)
BR112023008622A2 (https=)
CN305830570S (https=)
CN305801713S (https=)
CN305536741S (https=)
CN305536106S (https=)
CN305534935S (https=)
CN305534356S (https=)
CN305534003S (https=)
CN305531120S (https=)
CN305530866S (https=)
CN305530523S (https=)
CN305529845S (https=)
CN305528362S (https=)
CN305527815S (https=)
CN305453160S9 (https=)
CN306527697S (https=)
CN305551009S (https=)
CN305870555S (https=)
CN305869075S (https=)
CN305865021S (https=)
CN305857537S (https=)
CN305855730S (https=)
CN305852579S (https=)
CN305813851S (https=)